{"transactions":[{"id":727402,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:33:07.000Z","date":"2026-06-23","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (i) June 23, 2027, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after June 22, 2026. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy."}],"balance_after":28000,"derivative":{"exercise_price":8.35,"expiration_date":"2036-06-22","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001679039-26-000003","document":"form4-06242026_100601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000167903926000003/form4-06242026_100601.xml","form_type":"4"}},{"id":797890,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2026-04-29T11:14:41.000Z","date":"2026-04-24","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options disclosed on this Form 4 are time vested; 50 percent of the shares underlying the options awarded to the Reporting Person will vest on April 24, 2027, and 50 percent of them will vest in 24 equal monthly installments, subject to the Reporting Person remaining an employee of Immunic, Inc. in good standing through the relevant vesting date."}],"balance_after":300000,"derivative":{"exercise_price":8.8,"expiration_date":"2036-04-24","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001193805-26-000529","document":"e665406_4-panzara.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000529/e665406_4-panzara.xml","form_type":"4"}},{"id":809474,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-13T20:59:24.000Z","date":"2026-04-09","kind":"grant","planned":false,"acquired":true,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall be scheduled to vest monthly over a term of 24 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2026 Equity Incentive Plan) through the applicable vesting dates."}],"balance_after":28000,"derivative":{"exercise_price":9.54,"expiration_date":"2036-04-08","underlying":"Common Stock","underlying_shares":28000},"source":{"system":"sec-edgar","filing":"0001679039-26-000002","document":"form4-04132026_080418.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000167903926000002/form4-04132026_080418.xml","form_type":"4"}},{"id":1124251,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-03T21:36:21.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (i) May 30, 2026, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 30, 2025. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy."}],"balance_after":20900,"derivative":{"exercise_price":0.3125,"expiration_date":"2035-05-29","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001415889-25-015440","document":"form4-06032025_090615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000141588925015440/form4-06032025_090615.xml","form_type":"4"}},{"id":1501513,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-24T22:56:50.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (i) May 24, 2025, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 24, 2024. The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy."}],"balance_after":20900,"derivative":{"exercise_price":2.64,"expiration_date":"2034-05-23","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001415889-24-014573","document":"form4-05242024_100543.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000141588924014573/form4-05242024_100543.xml","form_type":"4"}},{"id":1882119,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-22T22:01:30.000Z","date":"2023-05-19","kind":"grant","planned":false,"acquired":true,"shares":20900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (i) May 19, 2024, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 19, 2023.  The option reported was granted pursuant to the terms of the Issuer's Outside Director Compensation Policy."}],"balance_after":20900,"derivative":{"exercise_price":2.89,"expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":20900},"source":{"system":"sec-edgar","filing":"0001209191-23-031559","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919123031559/doc4.xml","form_type":"4"}},{"id":2201247,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Option (right to buy)","published_at":"2022-07-28T01:05:15.000Z","date":"2022-07-25","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 50% of the shares on July 25, 2023 and 50% on July 25, 2024."}],"balance_after":60000,"derivative":{"exercise_price":2.83,"expiration_date":"2032-07-25","underlying":"Ordinary Shares","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0000899243-22-026922","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322026922/doc4.xml","form_type":"4"}},{"id":2252713,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-27T21:38:52.000Z","date":"2022-05-20","kind":"grant","acquired":true,"shares":2311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option will vest on the earlier of (i) May 20, 2023, or (ii) the day immediately before the date of the next annual meeting of the Issuer's stockholders that occurs after May 20, 2022.  The option reported was granted pursuant to the terms of the Issuer's outside director compensation policy."}],"balance_after":2311,"derivative":{"exercise_price":8.93,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":2311},"source":{"system":"sec-edgar","filing":"0001209191-22-032681","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122032681/doc4.xml","form_type":"4"}},{"id":2278962,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2022-05-06T23:05:17.000Z","date":"2022-05-05","kind":"sale","acquired":false,"shares":16714,"price":1.72,"value":28748.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On May 5, 2022, the reporting person sold 16,714 ordinary shares solely to cover taxes associated with the vesting of the PSUs on May 4, 2022. These sales were made pursuant to a provision in the reporting person's PSU agreement that requires automatic sales of shares to cover tax withholding obligations. The sales are intended to comply with Rule 10b5-1(c)(1)(i)(B) under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $1.72 to $1.75 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":109103,"source":{"system":"sec-edgar","filing":"0000899243-22-017130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322017130/doc4.xml","form_type":"4"}},{"id":2278961,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2022-05-06T23:05:17.000Z","date":"2022-05-04","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 7, 2019, the reporting person received performance-based restricted share units (\"PSUs\"), convertible on a one-for-one basis into ordinary shares of the issuer upon vesting. On May 4, 2022, 50% of the PSUs vested upon the issuer's achievement of the PN Chemistry Milestone (as defined in the PSU agreement) following the issuer's recent WVE-004 data release, as certified by the issuer's compensation committee."}],"balance_after":125817,"source":{"system":"sec-edgar","filing":"0000899243-22-017130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322017130/doc4.xml","form_type":"4"}},{"id":2322782,"issuer":{"id":1487,"kind":"organization","name":"LeonaBio, Inc.","symbol":"LONA"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-21T20:40:34.000Z","date":"2022-03-18","kind":"grant","acquired":true,"shares":27742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One thirty-sixth of the shares subject to the option will vest on April 18, 2022 and one thirty-sixth of the shares subject to the option will vest each month thereafter."}],"balance_after":27742,"derivative":{"exercise_price":10.62,"expiration_date":"2032-03-17","underlying":"Common Stock","underlying_shares":27742},"source":{"system":"sec-edgar","filing":"0001209191-22-020266","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620463/000120919122020266/doc4.xml","form_type":"4"}},{"id":2384723,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2022-02-18T23:00:20.000Z","date":"2022-02-16","kind":"sale","acquired":false,"shares":10603,"price":2.31,"value":24492.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2022, the reporting person sold 10,603 ordinary shares solely to cover taxes associated with the vesting of restricted share units (\"RSUs\") on February 15, 2022. These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $2.31 to $2.38 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":75817,"source":{"system":"sec-edgar","filing":"0000899243-22-007059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322007059/doc4.xml","form_type":"4"}},{"id":2447258,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Option (right to buy)","published_at":"2022-01-05T02:18:38.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 25% of the shares on January 1, 2023 and vests as to an additional 6.25% of the shares quarterly thereafter until January 1, 2026."}],"balance_after":200000,"derivative":{"exercise_price":3.14,"expiration_date":"2032-01-01","underlying":"Ordinary Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-22-000668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924322000668/doc4.xml","form_type":"4"}},{"id":2848802,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Share Option (right to buy)","published_at":"2021-02-19T00:16:47.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 50% of the shares on February 15, 2022 and 50% on February 15, 2023."}],"balance_after":50000,"derivative":{"exercise_price":10.48,"expiration_date":"2031-02-01","underlying":"Ordinary Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-21-007206","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321007206/doc4.xml","form_type":"4"}},{"id":2848801,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:16:47.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":2929,"price":10.57,"value":30959.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On February 16, 2021, the reporting person sold 2,929 ordinary shares solely to cover taxes associated with the vesting of RSUs on February 15, 2021. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $10.47 to $10.58 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":86420,"source":{"system":"sec-edgar","filing":"0000899243-21-007206","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321007206/doc4.xml","form_type":"4"}},{"id":2848800,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Ordinary Shares","published_at":"2021-02-19T00:16:47.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs). The RSUs vest in two equal installments on February 15, 2022 and February 15, 2023."}],"balance_after":89349,"source":{"system":"sec-edgar","filing":"0000899243-21-007206","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924321007206/doc4.xml","form_type":"4"}},{"id":3224063,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Share Option (right to buy)","published_at":"2020-03-06T01:40:02.000Z","date":"2020-03-03","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 50% of the shares on February 1, 2021 and 50% on February 1, 2022"}],"balance_after":36000,"derivative":{"exercise_price":8.17,"expiration_date":"2030-03-03","underlying":"Ordinary Shares","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0000899243-20-007277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924320007277/doc4.xml","form_type":"4"}},{"id":3258733,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-20T23:26:02.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":2981,"price":7.85,"value":23400.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 18, 2020, the reporting person sold 2,981 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2020. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $7.84 to $8.17 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":39349,"source":{"system":"sec-edgar","filing":"0000899243-20-005351","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924320005351/doc4.xml","form_type":"4"}},{"id":3465021,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-07-09T22:11:44.000Z","date":"2019-07-05","kind":"sale","acquired":false,"shares":445,"price":27.26,"value":12130.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of sale of restricted share units (RSUs) effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019."}],"balance_after":42330,"source":{"system":"sec-edgar","filing":"0000899243-19-019395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/doc4.xml","form_type":"4"}},{"id":3465020,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2019-07-09T22:11:44.000Z","date":"2019-07-05","kind":"sale","acquired":false,"shares":2613,"price":26.88,"value":70237.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of sale of restricted share units (RSUs) effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $26.25 to $27.21 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":42775,"source":{"system":"sec-edgar","filing":"0000899243-19-019395","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924319019395/doc4.xml","form_type":"4"}},{"id":3601131,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Ordinary Shares","published_at":"2019-03-11T23:18:12.000Z","date":"2019-03-11","kind":"sale","acquired":false,"shares":7000,"price":48,"value":336000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Consists of sale of RSUs effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2018."}],"balance_after":45388,"source":{"system":"sec-edgar","filing":"0000899243-19-007113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/doc4.xml","form_type":"4"}},{"id":3601130,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Ordinary Shares","published_at":"2019-03-11T23:18:12.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs).  The RSUs vest in four equal annual installments of 25% on February 15, 2020 through February 15, 2023."}],"balance_after":52388,"source":{"system":"sec-edgar","filing":"0000899243-19-007113","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924319007113/doc4.xml","form_type":"4"}},{"id":3641011,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Ordinary Shares","published_at":"2019-02-22T00:53:50.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":1837,"price":36.8394,"value":67673.9778,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 19, 2019, the reporting person sold 1,837 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2019. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $36.83 to $37.4713 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":37388,"source":{"system":"sec-edgar","filing":"0000899243-19-004466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924319004466/doc4.xml","form_type":"4"}},{"id":4043304,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Ordinary Shares","published_at":"2018-02-22T00:17:18.000Z","date":"2018-02-16","kind":"sale","acquired":false,"shares":511,"price":52.1,"value":26623.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 16, 2018, the reporting person sold 511 ordinary shares solely to cover taxes associated with the vesting of restricted share units on February 15, 2018. These sales were made pursuant to a 10b5-1 Trading Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $51.75 to $52.10 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":39225,"source":{"system":"sec-edgar","filing":"0000899243-18-004951","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924318004951/doc4.xml","form_type":"4"}},{"id":4046614,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Share Option (right to buy)","published_at":"2018-02-21T00:34:25.000Z","date":"2018-02-15","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The share option represented a right to purchase a total of 150,000 ordinary shares, 25% of which became exercisable on July 11, 2017, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":131250,"derivative":{"exercise_price":21.69,"expiration_date":"2026-07-11","underlying":"Ordinary Shares","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0000899243-18-004667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924318004667/doc4.xml","form_type":"4"}},{"id":4046613,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Ordinary Shares","published_at":"2018-02-21T00:34:25.000Z","date":"2018-02-15","kind":"sale","acquired":false,"shares":18750,"price":50,"value":937500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017."}],"balance_after":39736,"source":{"system":"sec-edgar","filing":"0000899243-18-004667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924318004667/doc4.xml","form_type":"4"}},{"id":4046612,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Ordinary Shares","published_at":"2018-02-21T00:34:25.000Z","date":"2018-02-15","kind":"exercise","acquired":true,"shares":18750,"price":21.69,"value":406687.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017."}],"balance_after":58486,"source":{"system":"sec-edgar","filing":"0000899243-18-004667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924318004667/doc4.xml","form_type":"4"}},{"id":4089440,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Share Option (right to buy)","published_at":"2018-01-26T01:05:49.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on February 15, 2019 and vests as to an additional 6.25% of the shares quarterly thereafter until February 15, 2022."}],"balance_after":35000,"derivative":{"exercise_price":40.05,"expiration_date":"2028-01-23","underlying":"Ordinary Shares","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000899243-18-002039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924318002039/doc4.xml","form_type":"4"}},{"id":4089439,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Ordinary Shares","published_at":"2018-01-26T01:05:49.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs).  The RSUs vest in four equal annual installments of 25% on February 15, 2019, through February 15, 2022."}],"balance_after":39736,"source":{"system":"sec-edgar","filing":"0000899243-18-002039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924318002039/doc4.xml","form_type":"4"}},{"id":4257569,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Franchise Lead, Neurology"}}],"security":"Ordinary Shares","published_at":"2017-07-13T21:09:57.000Z","date":"2017-07-12","kind":"sale","acquired":false,"shares":7414,"price":16.6738,"value":123619.5532,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 12, 2017, the reporting person sold 7,414 ordinary shares solely to cover taxes associated with the vesting of restricted share units on July 11, 2017. These sales were made pursuant to a 10b5-1 Trading Plan entered into solely for the purpose described in the prior sentence."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reflected is the weighted-average sale price for shares sold. The shares were sold in multiple transactions and the range of sale prices for the transactions reported was $16.55 to $16.95 per share. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":15336,"source":{"system":"sec-edgar","filing":"0000899243-17-018236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924317018236/doc4.xml","form_type":"4"}},{"id":4478815,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Neurology Franchise"}}],"security":"Share Option (right to buy)","published_at":"2017-01-27T23:13:44.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":13800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% of the shares on February 15, 2018 and vests as to an additional 2.0833% of the shares monthly thereafter until February 15, 2021."}],"balance_after":13800,"derivative":{"exercise_price":29.05,"expiration_date":"2027-01-25","underlying":"Ordinary Shares","underlying_shares":13800},"source":{"system":"sec-edgar","filing":"0000899243-17-002144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924317002144/doc4.xml","form_type":"4"}},{"id":4478814,"issuer":{"id":4976,"kind":"organization","name":"Wave Life Sciences, Inc.","symbol":"WVE"},"owners":[{"id":35596,"kind":"person","name":"Panzara Michael A.","position":1,"cik":"0001679039","reported_name":"Panzara Michael A.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Head of Neurology Franchise"}}],"security":"Ordinary Shares","published_at":"2017-01-27T23:13:44.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":6900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted share units (RSUs).  The RSUs vest in four equal annual installments of 25% on February 15, 2018, through February 15, 2021."}],"balance_after":29650,"source":{"system":"sec-edgar","filing":"0000899243-17-002144","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1631574/000089924317002144/doc4.xml","form_type":"4"}}]}